Synapse - Works

Results (2683)

Phase I/II study of sorefenib and erlotinib for patients with recurrent glioblastoma (GBM) (NABTC 05-02)

Meeting Abstract

Prados, M.; Gilbert, M.; Kuhn, J.; Lamborn, K.; Cloughesy, T.; Lieberman, F.; Puduvalli, V.; Robins, H. I.; Lassman, A.; Wen, P. Y.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin

Meeting Abstract

Price, K.; Kris, M. G.; Rusch, V.; Finley, D. J.; Azzoli, C. G.; Downey, R. J.; Bains, M. S.; Miller, V. A.; Rizk, N.; Rizvi, N. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

The clinical impact and outcomes of immunohistochemistry-only metastases in breast cancer

Meeting Abstract

Pugliese, M. S.; Stempel, M. M.; Patil, S. M.; Hsu, M.; Cody, H. S. 3rd; Morrow, M.; Gemignani, M. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase Ib dose finding trial of intravenous panobinostat with docetaxel in patients with castration-resistant prostate cancer (CRPC)

Meeting Abstract

Rathkopf, D. E.; Chi, K. N.; Vaishampayan, U.; Hotte, S.; Vogelzang, N.; Alumkal, J.; Agrawal, M.; Nydam, T. M.; Fandi, A.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A placebo-controlled study investigating the dexamethasone-sparing effects of corticorelin acetate in patients with primary or metastatic brain tumors and peritumoral edema

Meeting Abstract

Recht, L. D.; Mechtler, L.; Phuphanich, S.; Hormigo, A.; Hines, V.; Milsted, R.; O'Connor, P. C.; Ryan, R. P.; Wong, E. T.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts)

Meeting Abstract

Reid, A. H.; Attard, G.; Danila, D.; Ryan, C. J.; Thompson, E.; Kheoh, T.; Molina, A.; Small, E.; Scher, H.; De-Bono, J. S.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results

Meeting Abstract

Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Effect of ipilimumab treatment on 18-month survival: Update of patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials

Meeting Abstract

O'Day, S.; Weber, J.; Lebbe, C.; Maio, M.; Pehamberger, H.; Harmankaya, K.; Siegel, J.; Hoos, A.; Humphrey, R.; Wolchok, J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone

Meeting Abstract

Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Comparison of the immunogenicity of Montanide ISA 51 adjuvant and cytokine-matured dendritic cells in a randomized controlled clinical trial of melanoma vaccines

Meeting Abstract

O'Neill, D. W.; Adams, S.; Goldberg, J. D.; Escalon, J. B.; Rolnitzky, L. M.; Cruz, C. M.; Angiulli, A.; Old, L.; Pavlick, A. C.; Bhardwaj, N.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save